MDG1 — Medigene AG Share News
0.000.00%
Last trade - 00:00- €2.51m
- -€8.97m
- €6.03m
Brief: Medigene AG Medigene Appoints Dr. Kai Pinkernell To Executive Management Board As Cmo/Cdo
Brief: Medigene AG Says Planned 2018 EBITDA Loss Of EUR 21 - 23 Mln
German stocks - Factors to watch on March 22
Brief: Medigene Receives Approvals For First Clinical Trial With MDG1011
Brief: Medigene Strengthens Its Patent Portfolio With US Patent On Tagged TCR
Brief: Medigene, RXi To Collaborate On Therapeutic T Cells
Brief: Medigene Sells US-Rights For Veregen, Raises 2017 Guidance
Brief: Medigene completes recruitment for Phase I/II DC vaccine trial in AML
Brief: Medigene says 9M immunotherapy revenue 3.4 mln eur
German stocks - Factors to watch on November 9
German stocks - Factors to watch on September 8
Brief: Medigene to issue new shares to settle Trianta milestone payment
Brief: Medigene H1 total revenue at EUR 4.9 mln
German stocks - Factors to watch on August 3
Brief: Medigene submits CTA for its first TCR clinical trial
Brief: Medigene sticks with guidance after Q1 operating loss
Brief: Medigene COO steps down
Brief: Medigene says raises 20.7 mln eur in private placement
Brief: Medigene revises collaboration with Mitsui Norin